Intervention 1: Adrenalectomy: Clinical Trials

1 trial of Intervention 1: Adrenalectomy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Intervention 1: Adrenalectomy: new trials by email Literature Review of Intervention 1: Adrenalectomy trials Research Report on Intervention 1: Adrenalectomy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
Intervention 1: Adrenalectomy, Intervention 2: Semaglutide - Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS)
Not applicableRecruitingUniversity of Texas Southwestern Medical Center752026-03-052026-03-27

Conditions studied

ACTH Syndrome, Ectopic (1)  ·  Adrenal incidentaloma (1)  ·  Cushing Syndrome (1)  ·  Insulin Resistance (1)  ·  Weight Loss (1)

Sponsors

University of Texas Southwestern Medical Center (1)

Countries

United States (1)

NIH funding

K23DK142038 (1)